Stimulant Abuser Groups to Engage in 12-Step

Phase 3

Completed

• Conditions: Drug Abuse
• Interventions: Behavioral: STAGE-12; Behavioral: Treatment as Usual

• Registration Number: NCT00573183
• Lead Sponsor: University of Washington

Brief Summary

The purpose of this study is to determine whether a combined group and individual 12-Step facilitative (TSF) intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes.

Detailed Description

This protocol is to evaluate the degree to which a combined group and individual 12-Step facilitative (TSF) intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes compared to treatment as usual (TAU) without STAGE-12 among stimulant abusers. The primary objective is to evaluate reduction in percent of days of stimulant use as measured by self-report. Secondary objectives include evaluating reduction in percent days of use of other substances, the degree to which STAGE-12 increases involvement in 12-step activities and attendance at 12-step meetings, and the extent to which such 12 -step involvement and meeting attendance mediate substance use outcomes.

Study Timeline

• Study First Submitted: 2007-12-13
• Study First Submitted QC: 2007-12-13
• Study First Posted: 2007-12-14
• Study Start: 2008-01
• Primary Completion: 2010-04
• Study Completion: 2010-04
• Results First Submitted: 2013-06-04
• Results First Submitted QC: 2013-12-09
• Results First Posted: 2014-01-29
• Status Verified: 2016-10
• Last Update Submitted: 2016-10-24
• Last Update Posted: 2016-12-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 471

Inclusion Criteria

• seeking outpatient treatment for stimulant abuse or dependence
• current diagnosis of stimulant abuse or dependence
• willing to participate in the protocol

Read More

Exclusion Criteria

• not sufficiently medically or psychiatrically stable
• pending legal action that would inhibit their participation in the study
• in need of detoxification from opiates

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
STAGE-12	STAGE-12	STAGE-12 received 3 individual and 5 group 12-step facilitation sessions focusing on 12-step principles plus an intensive referral in which counselors linked participants to community-based 12-step volunteers. These sessions took the place of 3 individual and 5 group sessions in the standard intensive outpatient drug treatment program and were integrated into treatment as usual.
Treatment as Usual	Treatment as Usual	Treatment as usual received standard care provided in intensive outpatient drug treatment program without the STAGE-12 components.

Primary Outcome Measures

Name	Time	Method
Days of Stimulant Use	6 months	Number of days of use of stimulant drugs within 30-day blocks across a 6-month post-baseline period

Secondary Outcome Measures

Name	Time	Method
Attendance at 12-step Meetings	6 months	Days of attendance at 12-step meetings within 30-day blocks across a 6-month post-baseline period

Trial Locations

Locations (10)

Gateway Community Services; 🇺🇸 Jacksonville, Florida, United States

ChangePoint, Inc.; 🇺🇸 Portland, Oregon, United States

Recovery Centers of King County; 🇺🇸 Seattle, Washington, United States

Maryhaven, Inc.; 🇺🇸 Columbus, Ohio, United States

Evergreen Manor, Inc.; 🇺🇸 Everett, Washington, United States

Willamette Family Treatment Services; 🇺🇸 Eugene, Oregon, United States

Hina Mauka Kaneohe Rehabilitation Services; 🇺🇸 Kaneohe, Hawaii, United States

Addiction Medicine Services (WPIC); 🇺🇸 Pittsburgh, Pennsylvania, United States

Nexus Recovery Center; 🇺🇸 Dallas, Texas, United States

Dorchester Alcohol and Drug Commission; 🇺🇸 Summerville, South Carolina, United States